|
P001
|
|
|
P002
|
|
|
P003
|
|
|
P004
|
Robotic assisted MRI-US fusion guided target saturation biopsy of the prostate – diagnostic accuracy and clinical implications
Discussion des posters modérés
Prostate (Communications libres ou Posters non-modérés)
C. Wetterauer
Conférencier
Universitätsspital BaselP. Trotsenko Universitätsspital BaselM. Matthias Universitätsspital BaselN. Keller Universtität BaselA. Meyer Universitätsspital BaselP. Brantner Universitätsspital BaselT. Vlajnic Universitätsspital BaselL. Bubendorf Universitätsspital BaselD. Winkel Universitätsspital BaselD. Winkel Universitätsspital BaselM. Kwiatkowski Kantonsspital AarauH. Seifert Universitätsspital Basel
|
|
P005
|
Accompanying the prostate cancer patient pathway: evaluation of novel clinical decision support software
Discussion des posters modérés
Prostate (Communications libres ou Posters non-modérés)
T. Horn
Conférencier
Universitätsspital BaselM. Henkel University Hospital Basel, Switzerland.F. Leboutte University Hospital BaselP. Trotsenko University Hospital BaselS. Dugas University Hospital BaselS. Sutter University Hospital BaselG. Ficht University Hospital BaselC. Engesser University Hospital BaselM. Matthias University Hospital BaselJ. Ebbing University Hospital BaselP. Cornford Liverpool University Hospitals NHS TrustH. Seifert University Hospital BaselB. Stieltjes University Hospital BaselC. Wetterauer University Hospital Basel
|
|
P006
|
Diagnostic accuracy of PSMA-PET-CT for pelvic lymph node staging in men with prostate cancer undergoing radical prostatectomy and pelvic lymph node dissection
Discussion des posters modérés
Prostate (Communications libres ou Posters non-modérés)
J. Grogg
Conférencier
University of Zurich, Zurich, SwitzerlandA. Affentranger University of Zurich, Zurich, SwitzerlandM. Wettstein University of Zurich, Zurich, SwitzerlandB. Kaufmann University of Zurich, Zurich, SwitzerlandN. Grossmann University of Zurich, Zurich, SwitzerlandD. Eberli University of Zurich, Zurich, SwitzerlandC. Poyet University of Zurich, Zurich, SwitzerlandT. Hermanns University of Zurich, Zurich, SwitzerlandC. Fankhauser Kantonsspital Luzern, Luzern, Switzerland
|
|
P007
|
|
|
P008
|
Analysis of tumor foci in HIFU-eligible patients undergoing radical prostatectomy
Discussion des posters modérés
Prostate (Communications libres ou Posters non-modérés)
J. Costa Dos Santos
Conférencier
HUG Hôpitaux Universitaires GenèveJ. Klein HUG Hôpitaux Universitaires GenèveJ. Gariani HUG Hôpitaux Universitaires GenèveJ. Tille HUG Hôpitaux Universitaires GenèveC. Iselin HUG Hôpitaux Universitaires GenèveG. Wirth HUG Hôpitaux Universitaires Genève
|
|
P009
|
3D Magnetic Resonance Imaging–based Printed Models of Prostate before and after focal therapy
Discussion des posters modérés
Prostate (Communications libres ou Posters non-modérés)
M. Martins
Conférencier
Imagerive/SIPCC. Rochat CUGB /SIPCS. Martinière Formed 3D printing, Av. de Tivoli 19bis, LausanneD. Georges Antoine CUGB - Générale Beaulieu/SIPCG. Mayor CUGB - Générale Beaulieu/ SIPCG. Wirth CUGB - Générale BeaulieuS. Regusci SIPC - Swiss International Prostate Center
|
|
P010
|
A new model for prediction of high-risk features among unfavorable intermediate risk prostate cancer patients
Discussion des posters modérés
Prostate (Communications libres ou Posters non-modérés)
L. Stolzenbach
Conférencier
L. Nocera IRCCS San Raffaele Scientific Institute, C. Collà-Ruvolo Federico II University of NaplesZ. Tian University of Montreal Health CenterT. Maurer University Hospital Hamburg-EppendorfD. Tilki University Hospital Hamburg-EppendorfM. Graefen University Hospital Hamburg-EppendorfP. Karakiewicz University of Montreal Health Center
|
|
P011
|
|
|
P012
|
Medium term outcomes of modern active surveillance in men with low to intermediate risk prostate cancer
Discussion des posters modérés
Prostate (Communications libres ou Posters non-modérés)
M. Zbinden
Conférencier
CHUV - University HospitalA. Rakauskas CHUV-Lausanne University HospitalC. Codeluppi CHUV LausanneL. Jolliet CHUV LausanneS. La Rosa Centre Hospitalier Universitaire Vaudois (CHUV)J. Meuwly Lausanne University Hospital and University of LausanneF. Herrera CHUV Centre hospitalier universitaire vaudoisP. Jichlinski Centre Hospitalier Universitaire Vaudois, CHUV
|
|
P013
|
|
|
P014
|
|
|
P015
|
|
|
P016
|
|
|
P017
|
|
|
P018
|
|
|
P019
|
Diagnostic accuracy of preoperative lymph node staging of bladder cancer: a concordance analysis of a multicenter cohort
Discussion des posters modérés
Vessie (Communications libres ou Posters non-modérés)
F. Wenk
Conférencier
Luzerner Kantonsspital (LUKS)C. Lonati Spedali Civili Hospital of Brescia, University of BresciaL. Mordasini Luzerner Kantonsspital (LUKS)L. Afferi Luzerner Kantonsspital (LUKS)O. De Cobelli European Institute of OncologyE. Di Trapani European Institute of OncologyA. Necchi San Raffaele HospitalF. Montorsi San Raffaele HospitalA. Briganti San Raffaele HospitalC. Simeone Spedali Civili Hospital of Brescia, University of BresciaS. Zamboni Spedali Civili Hospital of Brescia, University of BresciaG. Simone Regina Elena National Cancer Institute, Rome, ItalyR. Karnes Mayo Clinic, Rochester, MN, USAR. Karnes Mayo Clinic, Rochester, MN, USAK. Hendricksen The Netherlands Cancer Institute - Antoni van Leeuwenhoek HospitalM. Rink Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyC. Poyet Zurich University HospitalC. Fankhauser Luzerner Kantonsspital (LUKS)P. Baumeister Luzerner Kantonsspital (LUKS)A. Mattei Luzerner Kantonsspital (LUKS)M. Moschini Luzerner Kantonsspital (LUKS)
|
|
P020
|
|
|
P021
|
|
|
P022
|
Ureteral stenting does not increase the risk of metachronous upper tract urothelial carcinoma in patients with bladder cancer presenting with hydronephrosis in comparison with percutaneous nephrostomy: a multicenter analysis
Discussion des posters modérés
Vessie (Communications libres ou Posters non-modérés)
L. Afferi
Conférencier
Luzerner KantonsspitalC. Lonati Spedali Civili Hospital of Brescia, University of BresciaF. Montorsi San Raffaele Scientific Institute, Vita-Salute San Raffaele UniversityA. Briganti San Raffaele Scientific Institute, Vita-Salute San Raffaele UniversityA. Mari Careggi University HospitalA. Minervini Careggi University HospitalW. Krajewski Wroclaw Medical UniversityG. Simone IRCCS "Regina Elena" National Cancer InstituteG. Schulz LMU MuenchenP. Black Vancouver Prostate Centre, University of British ColumbiaM. Mir Istituto Valenciano de OncologiaM. Roumiguie CHU ToulouseJ. Teoh The Chinese University of Hong KongF. Soria University of TurinM. Roupret Pitié Salpétrière HospitalM. Ribal Hospital Clínic de BarcelonaE. Xylinas Bichat Hospital, Paris Descartes University, Paris, FranceS. Zamboni Spedali Civili Hospital of Brescia, University of BresciaC. Simeone Spedali Civili Hospital of Brescia, University of BresciaA. Antonelli Azienda Ospedaliera Universitaria Integrata di VeronaA. Tafuri Azienda Ospedaliera Universitaria Integrata di VeronaS. Albisinni Université Libre de BruxellesA. Mattei Luzerner KantonsspitalM. Alvarez-Maestro Hospital La Paz, MadridS. Shariat Vienna General HospitalM. Moschini Luzerner Kantonsspital
|
|
P023
|
Patient trajectories of a real-world cohort initiating neoadjuvant chemotherapy for localized muscle-invasive bladder cancer: a population-based study analyzed by a multi-state modelling framework
Discussion des posters modérés
Vessie (Communications libres ou Posters non-modérés)
M. Wettstein
Conférencier
Princess Margaret Cancer Centre, University Health Network, University of TorontoS. Pham ICESS. Qadri Princess Margaret Cancer Centre, University Health Network, University of TorontoK. Li Princess Margaret Cancer Centre, University Health Network, University of TorontoN. Liu ICEST. Hermanns Universitätsspital ZürichP. Chung Princess Margaret Cancer Centre, University Health Network, University of TorontoS. Sridhar Princess Margaret Cancer Centre, University Health Network, University of Toronto
|
|
P024
|
Neoadjuvant Chemotherapy in Elderly Patients with Upper Tract Urothelial Cancer: Oncologic Outcomes from a Multicenter Study
Discussion des posters modérés
Vessie (Communications libres ou Posters non-modérés)
N. Grossmann
Conférencier
Universitätsspital ZürichB. Pradere Comprehensive Cancer Center, Vienna General Hospital, Medical University of ViennaD. D'Andrea Comprehensive Cancer Center, Vienna General Hospital, Medical University of ViennaV. Schuettfort Comprehensive Cancer Center, Vienna General Hospital, Medical University of ViennaK. Mori Comprehensive Cancer Center, Vienna General Hospital, Medical University of ViennaP. Rajwa Comprehensive Cancer Center, Vienna General Hospital, Medical University of ViennaF. Quhal Comprehensive Cancer Center, Vienna General Hospital, Medical University of ViennaE. Laukhtina Comprehensive Cancer Center, Vienna General Hospital, Medical University of ViennaS. Katayama Comprehensive Cancer Center, Vienna General Hospital, Medical University of ViennaC. Fankhauser Luzerner KantonsspitalE. Xylinas Bichat Hospital, Paris Descartes UniversityV. Margulis University of Texas Southwestern Medical CenterM. Moschini Luzerner KantonsspitalM. Abufaraj Jordan University HospitalM. Bandini IRCCS Ospedale San RaffaeleC. Lonati Luzerner KantonsspitalP. Nyirady Semmelweis UniversityP. Karakiewicz University of Montreal Health CenterH. Fajkovic Comprehensive Cancer Center, Vienna General Hospital, Medical University of ViennaS. Shariat Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna
|
|
P025
|
|
|
P026
|
|
|
P027
|
Survival outcomes of urothelial carcinoma with squamous differentiation versus pure squamous cell carcinoma after conservative management among BCa T1 patients
Discussion des posters modérés
Vessie (Communications libres ou Posters non-modérés)
F. Wenk
Conférencier
Luzerner Kantonsspital (LUKS)C. Lonati Spedali Civili Hospital of Brescia, University of BresciaL. Afferi Luzerner Kantonsspital (LUKS)P. Baumeister Luzerner Kantonsspital (LUKS)A. Minervini Careggi University HospitalA. Mari Careggi University HospitalW. Krajewski Wroclaw Medical UniversityM. Borghesi San Martino HospitalM. Rink Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyF. Montorsi San Raffaele HospitalA. Briganti San Raffaele HospitalR. Hurle Humanitas Clinical and Research Center IRCCSR. Contieri Humanitas Clinical and Research Center IRCCSP. Umari Maggiore della carità T. Klatte royal bournemouthJ. Teoh Prince of WalesF. Soria San Giovanni Battista Hospital, University of TurinC. Simeone Spedali Civili Hospital of Brescia, University of BresciaS. Zamboni Spedali Civili Hospital of Brescia, University of BresciaM. Roumiguie CHU ToulouseM. Roupret La Pitie Hospital Medecine Sorbonne Universite ParisA. Masson-Lecomte La Pitie Hospital Medecine Sorbonne Universite ParisS. Einerhand The Netherlands Cancer Institute - Antoni van Leeuwenhoek HospitalC. Fankhauser Luzerner Kantonsspital (LUKS)A. Mattei Luzerner Kantonsspital (LUKS)M. Moschini Luzerner Kantonsspital (LUKS)
|
|
P028
|
Survival outcomes after radical cystectomy versus conservative management for T1 high grade non-muscle-invasive squamous bladder cancer: a multicentre collaboration by the European Association of Urology–Young Academic Urologists
Discussion des posters modérés
Vessie (Communications libres ou Posters non-modérés)
C. Lonati
Conférencier
Spedali Civili Hospital of Brescia, University of BresciaP. Baumeister Luzerner Kantonsspital (LUKS)L. Afferi Luzerner Kantonsspital (LUKS)A. Mari Careggi University HospitalA. Minervini Careggi University HospitalW. Krajewski Wroclaw Medical UniversityM. Borghesi San Martino HospitalG. Schulz Ludwig-Maximilians-Universität MünchenM. Rink University Medical Center Hamburg-EppendorfF. Montorsi San Raffaele HospitalA. Briganti San Raffaele HospitalR. Hurle Humanitas Clinical and Research Center IRCCSS. Zamboni Spedali Civili Hospital of Brescia, University of BresciaC. Simeone Spedali Civili Hospital of Brescia, University of BresciaF. Soria San Giovanni Battista Hospital, University of TurinJ. Teoh Prince of WalesM. Roumiguié CHU ToulouseM. Rouprêt La Pitie Hospital Medecine Sorbonne Universite ParisA. Masson-Lecomte La Pitie Hospital Medecine Sorbonne Universite ParisM. Mir Istituto Valenciano de OncologiaA. Antonelli Azienda Ospedaliera Universitaria Integrata di VeronaK. Hendricksen The Netherlands Cancer Institute - Antoni van Leeuwenhoek HospitalC. Fankhauser Luzerner Kantonsspital (LUKS)A. Mattei Luzerner Kantonsspital (LUKS)M. Moschini Luzerner Kantonsspital (LUKS)
|
|
P029
|
|
|
P030
|
|
|
P031
|
|
|
P032
|
|
|
P033
|
Antibiotic resistance in UTI pathogens: Challenges facing the urologists
Discussion des posters modérés
Voies urinaires basses (Posters modérés)
S. D’Incau Insel University Hospital BernA. Atkinson Insel University Hospital BernL. Leitner
Conférencier
Balgrist University HospitalA. Kronenberg University of BernT. Kessler Balgrist University HospitalJ. Marschall Insel University Hospital Bern
|
|
P034
|
Engineered Bacteriophages as Antibiotic Alternatives for treating Catheter Associated Urinary Tract Infections (CAUTIphage)
Discussion des posters modérés
Voies urinaires basses (Posters modérés)
L. Leitner Balgrist University HospitalS. McCallin
Conférencier
Balgrist University HospitalV. Neumeier Balgrist University HospitalS. Kilcher Federal Institute of Technology (ETHZ)M. Dunne Federal Institute of Technology (ETHZ)J. Du Federal Institute of Technology (ETHZ)J. Klumpp Federal Institute of Technology (ETHZ)J. Marschall Insel University Hospital BerneM. Loessner Federal Institute of Technology (ETHZ)T. Kessler Balgrist University Hospital
|
|
P035
|
A sham-controlled trial of sacral neuromodulation for neurogenic bladder
Discussion des posters modérés
Voies urinaires basses (Posters modérés)
M. Liechti
Conférencier
Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandS. van der Lely Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandS. Knüpfer Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandD. Abt Department of Urology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandB. Kiss Department of Urology, Bern University Hospital, University of Bern, SwitzerlandL. Leitner Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandL. Mordasini Department of Urology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandJ. Tornic Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandJ. Wöllner Neuro-Urology, Swiss Paraplegic Center, Nottwil, SwitzerlandU. Mehnert Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandL. Bachmann Medignition Inc., Research Consultants, Zürich, SwitzerlandF. Burkhard Department of Urology, Bern University Hospital, University of Bern, SwitzerlandD. Engeler Department of Urology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandJ. Pannek Neuro-Urology, Swiss Paraplegic Center, Nottwil, Switzerland and Department of Urology, Inselspital, Bern University Hospital, University of Bern, SwitzerlandT. Kessler Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland
|
|
P036
|
Analysis of signal and contrast in a multi-echo gradient-echo sequence of the lumbosacral cord: recommendations for number of echoes and repetitions for prospective neuro-urological studies
Discussion des posters modérés
Voies urinaires basses (Posters modérés)
S. Büeler
Conférencier
Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandM. Yiannakas NMR Research Unit, Queens Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London, United KingdomZ. Damjanovski Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandT. Kessler Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandM. Liechti Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandP. Freund Spinal Cord Injury Center, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandG. David Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland
|
|
P037
|
Development of an appropriate sham procedure to investigate transcutaneous tibial nerve stimulation in randomized, sham-controlled, double-blind clinical trials
Discussion des posters modérés
Voies urinaires basses (Posters modérés)
S. Stalder
Conférencier
Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandM. Liechti Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandS. van der Lely Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandV. Birkhäuser Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandC. Anderson Swiss Paraplegic Research, Nottwil, Switzerland; Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland; Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandJ. Tornic Urologische Klinik, Kantonsspital Winterthur, Winterthur, SwitzerlandU. Mehnert Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandT. Kessler Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland
|
|
P038
|
|
|
P039
|
A dormant chance to better assess and understand human lower urinary tract afferent nerve function: A systematic review and meta-analysis
Discussion des posters modérés
Voies urinaires basses (Posters modérés)
S. van der Lely
Conférencier
Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandM. Schmidhalter Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandS. Knüpfer Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandA. Sartori Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandM. Schneider Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandS. Stalder Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandT. Kessler Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandM. Liechti Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandU. Mehnert Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland
|
|
P040
|
|
|
P041
|
|
|
P042
|
Earlier detection of recurrences using serum micro-RNA371 during active surveillance in men with stage I testicular germ cell tumours in the Swiss Austrian German Testicular Cancer Cohort Study
Posters non-modérés
Voies urinaires basses (Posters modérés)
C. Fankhauser
Conférencier
Luzerner KantonsspitalA. Christiansen Universitäts Spital ZürichC. Rothermundt Kantonsspital St. GallenR. Cathomas Kantonsspital GraubündenM. Wettstein Department of Urology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandN. Grossmann Department of Urology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandJ. Grogg Department of Urology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandA. Templeton Department of Medical Oncology, St. Claraspital Basel and Faculty of Medicine, University of Basel, Basel, SwitzerlandA. Hirschi-Blickenstorfer Onkozentrum Hirslanden, Klinik Hirslanden, Zürich, SwitzerlandA. Lorch Department of Oncology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandS. Gillessen EOC Oncology Institute of Southern Switzerland, Bellinzona, SwitzerlandH. Moch Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandJ. Beyer Department of Medical Oncology, Inselspital, University Hospital, University of Bern, Bern, SwitzerlandT. Hermanns Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
|
|
P043
|
|
|
P044
|
Risk of inguinal lymph node metastases in men with T1G2 penile cancer stratified by lymphovascular invasion
Discussion des posters modérés
Voies urinaires basses (Posters modérés)
C. Fankhauser
Conférencier
Luzerner KantonsspitalH. de Vries Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The NetherlandsE. Roussel Department of Urology, University Hospitals Leuven, Leuven, BelgiumJ. Jakobsen Department of Urology, Aarhus University Hospital, Aarhus, DenmarkA. Issa Department of Urology and Pathology, The Christie NHS Foundation Trust, Manchester, UKE. Lee Department of Urology and Pathology, The Christie NHS Foundation Trust, Manchester, UKP. Oliveira Department of Pathology, The Christie NHS Foundation Trust, Manchester, UKM. Lau Department of Urology and Pathology, The Christie NHS Foundation Trust, Manchester, UKA. Parnham Department of Urology and Pathology, The Christie NHS Foundation Trust, Manchester, UKM. Albersen Department of Urology, University Hospitals Leuven, Leuven, BelgiumN. Watkin Department of Urology, St George's Hospital, London, UKB. Ayres Department of Urology, St George's Hospital, London, UKO. Brouwer Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The NetherlandsV. Sangar Manchester academic health sciences centre, Manchester, UK
|
|
P045
|
Introduction of the Swiss second-opinion online portal on germ cell tumours
Discussion des posters modérés
Voies urinaires basses (Posters modérés)
C. Fankhauser
Conférencier
Luzerner KantonsspitalT. Hermanns Univeristät Zürich, Unispital ZürichD. Berthold CHUV Centre Hospitalier Universitaire Vaudois (CHUV)P. Bode Univeristät Zürich, Unispital ZürichR. Cathomas Richard.Cathomas@ksgr.chS. Gillessen EOC Oncology Institute of Southern Switzerland, Bellinzona, SwitzerlandA. Lorch Univeristät Zürich, Unispital ZürichA. Omlin Kantonspital St. GallenA. Papachristofilou Unispital BaselB. Roth CHUV Centre Hospitalier Universitaire Vaudois (CHUV)R. Seiler-Blarer Spitalzentrum BielM. Spahn PraxisF. Stenner Unispital BaselJ. Beyer Inselspital - Universitätsspital Bern
|
|
P046
|
|
|
P047
|
|
|
P048
|
|
|
P049
|
|
|
P050
|
|
|
P051
|
|
|
P052
|
|
|
P053
|
Should the follow-up schedule after radical nephroureterectomy be revised? An analysis on the timing and location of recurrences
Discussion des posters modérés
Rein (Posters modérés)
A. Martini San Raffaele HospitalC. Lonati
Conférencier
Spedali Civili Hospital of Brescia, University of BresciaA. Stabile San Raffaele HospitalA. Necchi San Raffaele HospitalA. Briganti San Raffaele HospitalF. Montorsi San Raffaele HospitalL. Afferi Luzerner Kantonsspital (LUKS)C. Fankhauser Luzerner Kantonsspital (LUKS)A. Mattei Luzerner Kantonsspital (LUKS)S. Shariat Comprehensive Cancer Center, Medical University of Vienna, Vienna General HospitalM. Moschini Luzerner Kantonsspital (LUKS)
|
|
P054
|
Perioperative safety and short-term oncological outcomes of minimally invasive retroperitoneal lymph node dissection
Discussion des posters modérés
Rein (Posters modérés)
C. Fankhauser
Conférencier
Luzerner KantonsspitalL. Afferi Luzerner KantonsspitalS. Stroup Department of Urology, Naval Medical Center San Diego, California, United States of AmericaN. Rocco Department of Urology, Naval Medical Center San Diego, California, United States of AmericaK. Olson Department of Urology, Mayo Clinic Hospital, Phoenix, Arizona, United States of AmericaA. Bagrodia Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of AmericaW. Cazzaniga Department of Urology, The Royal Marsden NHS Foundation Trust, London and Sutton, United KingdomE. Mayer Department of Urology, The Royal Marsden NHS Foundation Trust, London and Sutton, United KingdomD. Nicol Department of Urology, The Royal Marsden NHS Foundation Trust, London and Sutton, United KingdomE. Islamoglu Department of Urology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, TurkeyS. de Vergie Department of Urology and Transplantation Surgery, University Hospital Center, Nantes, FranceR. Saoud Section of Urology, Department of Surgery, University of Chicago Medical Center, Chicago, Illinois, United States of AmericaS. Eggener Section of Urology, Department of Surgery, University of Chicago Medical Center, Chicago, Illinois, United States of AmericaS. Nazzan Department of Urology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, ItalyN. Nicolai Department of Urology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, ItalyL. Huga Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida, United States of AmericaW. Sexton Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida, United States of AmericaD. Matei Department of Urology, European Institute of Oncology, Milan, ItalyP. Pierorazio Department of Urology, The Johns Hopkins Medical Institutions and The James Brady Buchannan Urological Institute, Baltimore, Maryland, United States of AmericaJ. Porter Department of Urology, Department of Urology, University of Washington School of Medicine, Seattle, Washington, United States of AmericaT. Hermanns Department of Urology, University of Zurich, Zurich, SwitzerlandR. Hamilton Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, CanadaA. Hiester Department of Urology, University of Duesseldorf, Medical Faculty, Heinrich-Heine-University, Duesseldorf, GermanyP. Albers Department of Urology, University of Duesseldorf, Medical Faculty, Heinrich-Heine-University, Duesseldorf, GermanyN. Clarke Department of Urology, The Christie NHS Foundation Trusts, Manchester, United KingdomA. Mattei Luzerner Kantonsspital
|
|
P055
|
Bladder Cancer: Patient-Derived Organoids as a Tool for Precision Medicine
Discussion des posters modérés
Recherche fondamentale (Posters modérés)
M. Minoli
Conférencier
University of BernM. Kiener University of BernT. Fedrizzi University of TrentoF. Demichelis University of TrentoG. Thalmann University Hospital of BernR. Seiler-Blarer University Hospital of BernM. Kruithof-de Julio University of Bern
|
|
P056
|
Somatic features of response and relapse in non-muscle invasive bladder cancer treated with intravesical Bacillus Calmette–Guérin
Discussion des posters modérés
Recherche fondamentale (Posters modérés)
D. Müller
Conférencier
University Hospital Basel / University of BaselJ. Bacon Vancouver Prostate Centre, University of British ColumbiaS. Dugas University Hospital Basel / University of BaselE. Ritch Vancouver Prostate Centre, University of British ColumbiaG. Vandekerkhove Vancouver Prostate Centre, University of British ColumbiaA. Contreras-Sanz Vancouver Prostate Centre, University of British ColumbiaM. Annala Faculty of Medicine and Life Sciences and BioMediTech Institute, University of TampereP. Black Vancouver Prostate Centre, University of British ColumbiaL. Bubendorf University Hospital Basel / University of BaselH. Seifert University Hospital Basel / University of BaselA. Wyatt Vancouver Prostate Centre, University of British ColumbiaC. Rentsch University Hospital Basel / University of Basel
|
|
P057
|
A Novel Patient-Derived Model of Sarcomatoid Urothelial Bladder Cancer
Discussion des posters modérés
Recherche fondamentale (Posters modérés)
M. Garioni
Conférencier
University Hospital Basel, Institute of Medical Genetics and Pathology and Department of UrologyI. Alborelli University Hospital Basel, Institute of Medical Genetics and PathologyT. Vlajnic University Hospital Basel, Institute of Medical Genetics and PathologyH. Pueschel University Hospital Basel, Dept. of UrologyL. Bubendorf University Hospital Basel, Institute of Medical Genetics and PathologyH. Seifert University Hospital Basel, Dept. of UrologyC. Rentsch University Hospital Basel, Dept. of UrologyC. Le Magnen University Hospital Basel, Institute of Medical Genetics and Pathology and Department of Urology
|
|
P058
|
Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens.
Discussion des posters modérés
Recherche fondamentale (Posters modérés)
R. Servant
Conférencier
Universitatsspital BaselM. Garioni Universitatsspital BaselT. Vlajnic Universitatsspital BaselM. Blind Universitatsspital BaselH. Pueschel Universitatsspital BaselD. Mueller Universitatsspital BaselT. Zellweger St. Claraspital, BaselA. Templeton St. Claraspital, BaselA. Garofoli Universitatsspital BaselS. Maletti Department for Biomedical Research, Faculty of Medicine, University of Bern, SwitzerlandM. Rubin Department for Biomedical Research, Faculty of Medicine, University of Bern, SwitzerlandL. Bubendorf Universitatsspital BaselH. Seifert Universitatsspital BaselC. Rentsch Universitatsspital BaselC. Le Magnen Universitatsspital Basel
|
|
P059
|
The role of CRIPTO signaling in lethal prostate cancer
Discussion des posters modérés
Recherche fondamentale (Posters modérés)
E. Rodrigues Sousa
Conférencier
University of BernE. Zoni University of BernM. De Menna University of BernG. Thalmann Univeristy Hospital of BernM. Kruithof-de Julio University of Bern
|
|
P060
|
|
|
P061
|
The potential role of CTLH complex in the prostate cancer
Discussion des posters modérés
Recherche fondamentale (Posters modérés)
M. Scarpa
Conférencier
University of BernM. De Menna University of BernE. Zoni University of BernS. Karkampouna University of BernM. Kruithof-de Julio University of Bern
|
|
P062
|
|
|
P063
|
Novel Urine Biomarkers for the Early Detection of Prostate Cancer
Discussion des posters modérés
Recherche fondamentale (Posters modérés)
N. Alijaj
Conférencier
University Hospital of Zurich, University of ZurichB. Pavlovic University Hospital of Zurich, University of ZurichP. Martel University Hospital of Lausanne (CHUV)L. Derré University Hospital of Lausanne (CHUV)M. Valerio University Hospital of Lausanne (CHUV)K. Saba Kantonsspital GraubündenC. Poyet University Hospital of Zurich, University of ZurichT. Hermanns University Hospital of Zurich, University of ZurichP. Oechslin University Hospital of Zurich, University of ZurichD. Eberli University Hospital of Zurich, University of ZurichI. Banzola University Hospital of Zurich, University of Zurich
|
|
P064
|
|
|
P065
|
Detrusor sphincter dyssynergia: Can a more specific definition distinguish between patients with and without an underlying neurological disorder?
Discussion des posters modérés
Recherche fondamentale (Posters modérés)
O. Gross
Conférencier
Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandL. Leitner Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandM. Rasenack Neurology, Spinal Cord Injury Center, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandM. Schubert Neurology, Spinal Cord Injury Center, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandT. Kessler Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland
|
|
P066
|
|
|
P067
|
|
|
P068
|
DaVinci-Salvageprostatektomie
Posters non-modérés
Prostate (Communications libres ou Posters non-modérés)
M. Braun
Conférencier
Uroviva AG Spital Männedorf
|
|
P070
|
An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate Cancer
Posters non-modérés
Prostate (Communications libres ou Posters non-modérés)
H. Haverdings
Conférencier
CHUV-Lausanne University HospitalA. Martini San Raffaele HospitalT. Soeterik St. Antonius ziekenhuis R. Rahota La Croix du Sud HospitalE. Checcucci San Luigi HospitalS. De Cillis San Luigi HospitalT. Hermanns University Hospital Zurich, University of ZurichC. Fankhauser University Hospital Zurich, University of ZurichL. Afferi Luzerner KantonsspitalM. Moschini Luzerner KantonsspitalA. Mattei Luzerner KantonsspitalC. Kesch University Hospital Essen, German Cancer I. Heidegger Medical University InnsbruckF. Preißer University Hospital Frankfurt am MainF. Zattoni San Giovanni Battista Hospital, University of TurinA. Marquis Academical Medical Centre Hospital, UdineG. Marra Academical Medical Centre Hospital, UdineP. Gontero Academical Medical Centre Hospital, UdineA. Briganti San Raffaele HospitalF. Montorsi San Raffaele HospitalF. Porpiglia San Luigi HospitalH. Haverdings St. Antonius ziekenhuisR. van den Bergh St. Antonius ziekenhuisH. van Melick St. Antonius ziekenhuisG. Ploussard La Croix du Sud HospitalG. Gandaglia San Raffaele HospitalM. Valerio CHUV-Lausanne University Hospital
|
|
P071
|
Visioning - Evaluation of a solely MRI-based, PSA-free prostate cancer screening program
Posters non-modérés
Prostate (Communications libres ou Posters non-modérés)
M. Matthias
Conférencier
Universitätsspital BaselC. Wetterauer Universitätsspital BaselH. Püschel Universitätsspital BaselL. Bubendorf Universitätsspital BaselD. Boll Universitätsspital BaselE. Merkle Universitätsspital BaselH. Seifert Universitätsspital BaselC. Rentsch Universitätsspital Basel
|
|
P072
|
|
|
P073
|
|
|
P074
|
Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 bladder cancer
Posters non-modérés
Vessie (Communications libres ou Posters non-modérés)
L. Afferi
Conférencier
Luzerner KantonsspitalC. Lonati Luzerner KantonsspitalF. Montorsi San Raffaele Scientific Institute, Vita-Salute San Raffaele UniversityA. Briganti San Raffaele Scientific Institute, Vita-Salute San Raffaele UniversityA. Necchi San Raffaele Scientific Institute, Vita-Salute San Raffaele UniversityA. Mari Careggi University HospitalA. Minervini Careggi University HospitalE. Di Trapani Istituto Europeo di OncologiaO. De Cobelli Istituto Europeo di OncologiaR. Karnes Mayo ClinicM. Ahmed Mayo ClinicM. Mir Istituto Valenciano de OncologiaM. Rink LMU MuenchenS. Zamboni Spedali Civili Hospital of Brescia, University of BresciaC. Simeone Spedali Civili Hospital of Brescia, University of BresciaW. Krajewski Wroclaw Medical UniversityE. Xylinas Bichat Hospital, Paris Descartes University, Paris, FranceF. Soria University of TurinK. Hendricksen Netherlands Cancer Institute - Antoni van Leeuwenhoek HospitalA. Mattei Luzerner KantonsspitalM. Roumiguie CHU ToulouseP. Black University of British ColumbiaS. Shariat Vienna General HospitalM. Moschini Luzerner Kantonsspital
|
|
P075
|
Selecting the best candidates for cisplatin-based adjuvant chemotherapy after radical cystectomy in pN+ bladder cancer patients
Posters non-modérés
Vessie (Communications libres ou Posters non-modérés)
L. Afferi
Conférencier
Luzerner KantonsspitalC. Lonati Luzerner KantonsspitalF. Montorsi San Raffaele Scientific Institute, Vita-Salute San Raffaele UniversityA. Briganti San Raffaele Scientific Institute, Vita-Salute San Raffaele UniversityA. Necchi San Raffaele Scientific Institute, Vita-Salute San Raffaele UniversityA. Mari Careggi University HospitalA. Minervini Careggi University HospitalG. Schulz LMU MuenchenP. Black Vancouver Prostate Centre, University of British ColumbiaE. Di Trapani Istituto Europeo di OncologiaO. De Cobelli Istituto Europeo di OncologiaR. Karnes Mayo Clinic, Rochester, MN, USAM. Ahmed Mayo Clinic, Rochester, MN, USAM. Mir Istituto Valenciano de OncologiaM. Rink Universitätsklinikum Hamburg EppendorfS. Zamboni Spedali Civili Hospital, University of BresciaC. Simeone Spedali Civili Hospital of Brescia, University of BresciaA. Antonelli University Hospital of VeronaA. Tafuri University Hospital of VeronaW. Krajewski Wroclaw Medical UniversityE. Xylinas Bichat-Claude Bernard HospitalF. Soria Università degli Studi di TorinoR. Sanchez-Salas Department of Urology, L'Institut Mutualiste Montsouris, Université Paris Descartes, Paris, FranceX. Cathelineau Department of Urology, L'Institut Mutualiste Montsouris, Université Paris Descartes, Paris, FranceK. Hendricksen Netherlands Cancer Institute - Antoni van Leeuwenhoek HospitalM. Borghesi University of GenoaF. Chierigo University of GenoaJ. Yuen-Chun Teoh The Chinese University of Hong KongA. Mattei Luzerner KantonsspitalS. Albisinni Université Libre de BruxellesF. Roghmann Ruhr University Bochum, GermanyM. Roumiguie CHU ToulouseE. Maier Klinik München-BogenhausenA. Aziz Klinik München-BogenhausenR. Hurle Humanitas Research HospitalC. Poyet Zurich University HospitalM. Alvarez-Maestro Hospital La Paz, MadridD. D’Andrea Vienna General HospitalS. Shariat Vienna General HospitalM. Moschini Luzerner Kantonsspital
|
|
P076
|
|
|
P077
|
Continuous local anesthetic wound infiltration for postoperative pain management improves surgical recovery after radical cystectomy.
Posters non-modérés
Vessie (Communications libres ou Posters non-modérés)
F. Crettenand
Conférencier
Centre Hospitalier Universitaire Vaudois (CHUV)N. Grilo Centre Hospitalier Universitaire Vaudois (CHUV)B. Roth Centre Hospitalier Universitaire Vaudois (CHUV)M. Valerio Centre Hospitalier Universitaire Vaudois (CHUV)S. Rodrigues Centre Hospitalier Universitaire Vaudois (CHUV)F. Dartiguenave Centre Hospitalier Universitaire Vaudois (CHUV)C. Blanc Centre Hospitalier Universitaire Vaudois (CHUV)J. Rouvé Centre Hospitalier Universitaire Vaudois (CHUV)I. Lucca Centre Hospitalier Universitaire Vaudois (CHUV)
|
|
P078
|
|
|
P079
|
Débitmètre à domicile
Posters non-modérés
Voies urinaires basses (Posters modérés)
J. Thomas
Conférencier
Hôpital du Jura Bernois, St-ImierJ. Lalive Hôpital intercantonal de la BroyeA. Coassin aucune
|
|
P080
|
|
|
P081
|
Higher lymph node counts in men with penile cancer undergoing robotic compared to laparoscopic or open pelvic lymph node dissection
Discussion des posters modérés
Voies urinaires basses (Posters modérés)
C. Fankhauser
Conférencier
Luzerner KantonsspitalE. Lee Department of Urology, The Christie NHS Foundation Trusts, Manchester, UKM. Lau Department of Urology, The Christie NHS Foundation Trusts, Manchester, UKV. Sangar Department of Urology, The Christie NHS Foundation Trusts, Manchester, UKA. Parnham Department of Urology, The Christie NHS Foundation Trusts, Manchester, UK
|
|
P082
|
|
|
P083
|
|
|
P084
|
|
|
P085
|
|
|
P086
|
|
|
P087
|
|
|
P088
|
|
|
P089
|
|
|
P090
|
|
|
P091
|
|
|
P092
|
Urological status at discharge from spinal cord injury rehabilitation centers implementing the EAU Neuro-Urology guidelines: a descriptive analysis from a population-based prospective cohort study
Posters non-modérés
Tous les thèmes (Posters non-modérés, Vidéo)
C. Anderson
Conférencier
Swiss Paraplegic Research, Nottwil; University of Lucerne, Lucerne, Switzerland; Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandV. Birkhäuser Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandX. Jordan Clinique Romande de Réadaptation, Sion, SwitzerlandM. Liechti Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandE. Luca Clinique Romande de Réadaptation, Sion, SwitzerlandS. Möhr Neuro-Urology, REHAB Basel, Basel, SwitzerlandJ. Pannek Neuro-Urology, Swiss Paraplegic Center, Nottwil, Switzerland; Department of Urology, Inselspital, Bern University Hospital, University of Bern, SwitzerlandT. Kessler Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, SwitzerlandM. Brinkhof Swiss Paraplegic Research, Nottwil, Switzerland; Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland
|
|
P093
|
Robot-assisted adrenalectomy for adrenal mass: A case series
Posters non-modérés
Tous les thèmes (Posters non-modérés, Vidéo)
M. Thüring
Conférencier
Klinik für Urologie Kantonsspital WinterthurB. Förster Klinik für Urologie Kantonsspital WinterthurC. Padevit Klinik für Urologie Kantonsspital WinterthurH. John Klinik für Urologie Kantonsspital Winterthur
|
|
P094
|
|
|
P095
|
|
|
P096
|
A longitudinal study evaluating interim assessment of neoadjuvant chemotherapy for bladder cancer
Posters non-modérés
Tous les thèmes (Posters non-modérés, Vidéo)
S. Lütolf
Conférencier
University Hospital of BernM. Furrer University Hospital of BernN. Papa Monash UniversityB. Roth University Hospital of Lausanne (CHUV)M. Cumberbatch University of SheffieldM. Dorin Vartolomei Comprehensive Cancer Center, Vienna General Hospital, Medical University of ViennaB. Thomas The University of Melbourne, Royal Melbourne HospitalH. Thoeny Hôpital Cantonal Fribourgois R. Seiler-Blarer University Hospital of BernG. Thalmann University Hospital of BernB. Kiss University Hospital of Bern
|
|
P097
|
|
|
P098
|
|
|
P099
|
|
|
P100
|
|
|
P101
|
|
|
P102
|
|
|
P103
|
Radical hemiscrotectomy and en-bloc orchidectomy: surgical technique, perioperative and oncologic outcomes of a supra-regional UK referral centre
Posters non-modérés
Tous les thèmes (Posters non-modérés, Vidéo)
C. Fankhauser
Conférencier
Luzerner KantonsspitalA. Issa Department of Urology, The Christie NHS Foundation Trusts, Manchester, UKE. Lee Department of Urology, The Christie NHS Foundation Trusts, Manchester, UKC. Oing Dept of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, University Medical Center Eppendorf, Hamburg, GermanyP. Oliveira Department of Urology, The Christie NHS Foundation Trusts, Manchester, UKA. Parnham Department of Urology, The Christie NHS Foundation Trusts, Manchester, UKJ. Oates Department of Urology, The Christie NHS Foundation Trusts, Manchester, UKV. Sangar Manchester University NHS Foundation Trust, Manchester, United KingdomA. Gulamhusein Department of Urology, The Christie NHS Foundation Trusts, Manchester, UKN. Clarke The Salford Royal NHS Foundation Trust, Manchester, United Kingdom
|
|
P104
|
Ensuring complete resection of extramammary Paget’s disease using a two staged approach: systematic mapping biopsies followed by personalised resection
Posters non-modérés
Tous les thèmes (Posters non-modérés, Vidéo)
C. Fankhauser
Conférencier
Luzerner KantonsspitalA. Issa Department of Urology, The Christie NHS Foundation Trust, Manchester, United KingdomP. Oliveira Department of Pathology, The Christie NHS Foundation Trust, Manchester, United KingdomA. Parnham Department of Urology, The Christie NHS Foundation Trust, Manchester, United KingdomM. Lau Department of Urology, The Christie NHS Foundation Trust, Manchester, United KingdomV. Sangar Manchester Academic Health Sciences Centre, University of Manchester, United Kingdom
|